Bloomberg TalksBloomberg Talks

Novo Nordisk CEO Talks Weight Loss Drug Supply

View descriptionShare

Novo Nordisk is shipping more introductory doses of its blockbuster weight-loss drug Wegovy in the US as it grapples with supply constraints and competition from Eli Lilly & Co. CEO Lars Fruergaard Jorgensen says the company will continue to ramp up supply of its popular weight-loss drug "gradually." He spoke with Bloomberg's Katie Greifeld and Romaine Bostick. 

  • Facebook
  • Twitter
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. Bloomberg Talks

    901 clip(s)

Bloomberg Talks

Curating today’s top interviews from around Bloomberg News. Hear conversations with the biggest name 
Social links
Follow podcast
Recent clips
Browse 903 clip(s)